Sanghyuk Chung to Mice, Transgenic
This is a "connection" page, showing publications Sanghyuk Chung has written about Mice, Transgenic.
Connection Strength
1.060
-
Estrogen Inhibits Epithelial Progesterone Receptor-Dependent Progestin Therapy Efficacy in a Mouse Model of Cervical Cancer. Am J Pathol. 2022 02; 192(2):353-360.
Score: 0.193
-
Progesterone Receptor Is a Haploinsufficient Tumor-Suppressor Gene in Cervical Cancer. Mol Cancer Res. 2021 01; 19(1):42-47.
Score: 0.180
-
Medroxyprogesterone Acetate Prevention of Cervical Cancer through Progesterone Receptor in a Human Papillomavirus Transgenic Mouse Model. Am J Pathol. 2019 12; 189(12):2459-2468.
Score: 0.168
-
Recurrence of cervical cancer and its resistance to progestin therapy in a mouse model. Oncotarget. 2017 Jan 10; 8(2):2372-2380.
Score: 0.138
-
Distinct functions and regulation of epithelial progesterone receptor in the mouse cervix, vagina, and uterus. Oncotarget. 2016 Apr 05; 7(14):17455-67.
Score: 0.131
-
Requirement of estrogen receptor alpha DNA-binding domain for HPV oncogene-induced cervical carcinogenesis in mice. Carcinogenesis. 2014 Feb; 35(2):489-96.
Score: 0.111
-
Progesterone signaling inhibits cervical carcinogenesis in mice. Am J Pathol. 2013 Nov; 183(5):1679-1687.
Score: 0.110
-
Recurrence of cervical cancer in mice after selective estrogen receptor modulator therapy. Am J Pathol. 2014 Feb; 184(2):530-40.
Score: 0.028